BCM
VIVE

BlueCrest Capital Management’s VIVEVE MED INC VIVE Stock Holding History

BlueCrest Capital Management’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-31
Closed -$84K – 1551
2018
Q3 		$84K Buy
31
+13
+72% +$36.8K ﹤0.01% 1405
2018
Q2 		$49K Buy
+18
New +$51.9K ﹤0.01% 1434

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

BlueCrest Capital Management's VIVE Position: Q4 2018 in Review

BlueCrest Capital Management sold out of VIVEVE MED INC (VIVE) in Q4 2018, closing a stake of 31 shares — an estimated $84K sold.

BlueCrest Capital Management first reported a position in VIVE in Q2 2018 and held it in 2 quarters. The position peaked at $84K in Q3 2018. 41 funds tracked by Wall St. Rank hold VIVE as of Q4 2018.

  • BlueCrest Capital Management reported no remaining VIVEVE MED INC position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 31 VIVEVE MED INC shares in Q4 2018, an estimated $84K.
  • BlueCrest Capital Management first reported a position in VIVEVE MED INC in Q2 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's VIVEVE MED INC position peaked at $84K in Q3 2018.
  • 41 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.